Meeting report: 6th Global Forum on Tuberculosis Vaccines, 22-25 February 2022, Toulouse, France

Safe, effective, and accessible vaccines are urgently needed to end tuberculosis (TB) by 2030. The 6th Global Forum on TB Vaccines, convened virtually 22-25 February 2022, was hosted by Toulouse, France, under the high patronage of President Emmanuel Macron, and the patronages of Minister for Solidarity and Health, Olivier Veran, and Minister for Higher Education, Research and Innovation, Frederique Vidal. The theme for the meeting, New horizons for TB vaccines, reflected the changing land-scape in which TB vaccine research and development (R&D) is being conducted: TB vaccines advancing into late-stage clinical trials and toward licensure, innovative research toward diversifying the TB vaccine pipeline and developing the next generation of candidates, increasing political, civil society, and commu-nity support for TB vaccines, and the ongoing COVID-19 pandemic. In this report, we summarize key themes and findings from the meeting, highlighting progress and gaps in the TB vaccine field.

Automated summary

Safe, effective, and accessible vaccines are urgently needed to end tuberculosis (TB) by 2030. The 6th Global Forum on TB Vaccines, hosted by Toulouse, France, highlighted the progress and gaps in TB vaccine research and development. The meeting discussed the advancement of TB vaccines into late-stage clinical trials, the diversification of the TB vaccine pipeline, increasing political and community support, and the impact of the ongoing COVID-19 pandemic on TB vaccine development.